Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma
Lacal, Atzori, Ruffini, Scimeca, Bonanno, Cicconi, Mattei, Bernardini, D'Atri, Tentori, Graziani (2020) Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma Pharmacol Res (IF: 9.3) 159 104957Links
http://www.ncbi.nlm.nih.gov/pubmed/32485280http://dx.doi.org/10.1016/j.phrs.2020.104957
